79 related articles for article (PubMed ID: 27114532)
1. Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding.
Wei X; Wu S; Song T; Chen L; Gao M; Borcherds W; Daughdrill GW; Chen J
Proc Natl Acad Sci U S A; 2016 May; 113(19):E2558-63. PubMed ID: 27114532
[TBL] [Abstract][Full Text] [Related]
2. Crystal Structures of Human MdmX (HdmX) in Complex with p53 Peptide Analogues Reveal Surprising Conformational Changes.
Kallen J; Goepfert A; Blechschmidt A; Izaac A; Geiser M; Tavares G; Ramage P; Furet P; Masuya K; Lisztwan J
J Biol Chem; 2009 Mar; 284(13):8812-21. PubMed ID: 19153082
[TBL] [Abstract][Full Text] [Related]
3. The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches.
Joerger AC; Fersht AR
Annu Rev Biochem; 2016 Jun; 85():375-404. PubMed ID: 27145840
[TBL] [Abstract][Full Text] [Related]
4. MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis.
Huang Q; Chen L; Yang L; Xie X; Gan L; Cleveland JL; Chen J
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3368-E3377. PubMed ID: 29581299
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3.
Yang P; Chen W; Li X; Eilers G; He Q; Liu L; Wu Y; Wu Y; Yu W; Fletcher JA; Ou WB
Oncotarget; 2016 May; 7(22):32652-63. PubMed ID: 27129163
[TBL] [Abstract][Full Text] [Related]
6. Dynamic surveillance of tamoxifen-resistance in ER-positive breast cancer by CAIX-targeted ultrasound imaging.
Li Y; Chen X; Zhou Z; Li Q; Westover KD; Wang M; Liu J; Zhang S; Zhang J; Xu B; Wei X
Cancer Med; 2020 Apr; 9(7):2414-2426. PubMed ID: 32048471
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of the ultrasound gray scale ratio for different sizes of thyroid nodules.
Chen X; Gao M; Hu L; Zhu J; Zhang S; Wei X
Cancer Med; 2019 Dec; 8(18):7644-7649. PubMed ID: 31691509
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of the biomarkers related to ferroptosis in calcium oxalate nephrolithiasis.
Hou C; Zhong B; Gu S; Wang Y; Ji L
Aging (Albany NY); 2024 Mar; 16(7):5987-6007. PubMed ID: 38536018
[TBL] [Abstract][Full Text] [Related]
9. MDMX in Cancer: A Partner of p53 and a p53-Independent Effector.
Lin W; Yan Y; Huang Q; Zheng D
Biologics; 2024; 18():61-78. PubMed ID: 38318098
[TBL] [Abstract][Full Text] [Related]
10. MDM4 was associated with poor prognosis and tumor-immune infiltration of cancers.
Liu J; Yang J; Pan Q; Wang X; Wang X; Chen H; Zheng X; Huang Q
Eur J Med Res; 2024 Jan; 29(1):79. PubMed ID: 38281029
[TBL] [Abstract][Full Text] [Related]
11. Protein disorder and autoinhibition: The role of multivalency and effective concentration.
Fenton M; Gregory E; Daughdrill G
Curr Opin Struct Biol; 2023 Dec; 83():102705. PubMed ID: 37778184
[TBL] [Abstract][Full Text] [Related]
12. FAM193A is a positive regulator of p53 activity.
Szwarc MM; Guarnieri AL; Joshi M; Duc HN; Laird MC; Pandey A; Khanal S; Dohm E; Bui AK; Sullivan KD; Galbraith MD; Andrysik Z; Espinosa JM
Cell Rep; 2023 Mar; 42(3):112230. PubMed ID: 36897777
[TBL] [Abstract][Full Text] [Related]
13. The MDMX Acidic Domain Uses Allovalency to Bind Both p53 and MDMX.
Fenton M; Borcherds W; Chen L; Anbanandam A; Levy R; Chen J; Daughdrill G
J Mol Biol; 2022 Nov; 434(22):167844. PubMed ID: 36181774
[TBL] [Abstract][Full Text] [Related]
14. Hesperidin Inhibits the p53-MDMXInteraction-Induced Apoptosis of Non-Small-Cell Lung Cancer and Enhances the Antitumor Effect of Carboplatin.
Feng Y; Huo H; Tang Q
J Oncol; 2022; 2022():5308577. PubMed ID: 36157229
[TBL] [Abstract][Full Text] [Related]
15. Cryptic in vitro ubiquitin ligase activity of HDMX towards p53 is probably regulated by an induced fit mechanism.
Calderon-González KG; Medina-Medina I; Haronikova L; Hernychova L; Bonczek O; Uhrik L; Hrabal V; Vojtesek B; Fahraeus R; Hernández-Monge J; Olivares-Illana V
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35674210
[TBL] [Abstract][Full Text] [Related]
16. Direct Interaction of miRNA and circRNA with the Oncosuppressor p53: An Intriguing Perspective in Cancer Research.
Bizzarri AR; Cannistraro S
Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885216
[TBL] [Abstract][Full Text] [Related]
17. Polyphenols as Antitumor Agents Targeting Key Players in Cancer-Driving Signaling Pathways.
Cháirez-Ramírez MH; de la Cruz-López KG; García-Carrancá A
Front Pharmacol; 2021; 12():710304. PubMed ID: 34744708
[TBL] [Abstract][Full Text] [Related]
18. MDMX Recruits UbcH5c to Facilitate MDM2 E3 Ligase Activity and Subsequent p53 Degradation
Yang J; Jin A; Han J; Chen X; Zheng J; Zhang Y
Cancer Res; 2021 Feb; 81(4):898-909. PubMed ID: 33277368
[TBL] [Abstract][Full Text] [Related]
19. Targeting Casein Kinase 1 (CK1) in Hematological Cancers.
Janovská P; Normant E; Miskin H; Bryja V
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261128
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
